MYRIAD MYRISK Trademark

Trademark Overview

On Monday, May 6, 2013, a trademark application was filed for MYRIAD MYRISK with the United States Patent and Trademark Office. The USPTO has given the MYRIAD MYRISK trademark a serial number of 85924742. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 11, 2022. This trademark is owned by Myriad Genetics, Inc.. The MYRIAD MYRISK trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease, excluding cardiovascular disease

Testing for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease; excluding cardiovascular disease; medical testing services for predicting disease and identifying risk factors of disease, excluding cardiovascular disease
myriad myrisk

General Information

Serial Number85924742
Word MarkMYRIAD MYRISK
Filing DateMonday, May 6, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 11, 2022
Registration Number4860135
Registration DateTuesday, November 24, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Pseudo MarkMYRIAD MY RISK
Goods and ServicesMedical test kits consisting of test forms, mailing materials, user information inserts, and specimen collection tubes and containers for collecting patient specimens for detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease, excluding cardiovascular disease
Goods and ServicesTesting for medical purposes, namely, providing reference and clinical laboratory tests which detect gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease; excluding cardiovascular disease; medical testing services for predicting disease and identifying risk factors of disease, excluding cardiovascular disease

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, May 13, 2013
Primary Code010
First Use Anywhere DateTuesday, September 3, 2013
First Use In Commerce DateTuesday, September 3, 2013
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 13, 2013
Primary Code044
First Use Anywhere DateTuesday, September 3, 2013
First Use In Commerce DateTuesday, September 3, 2013

Trademark Owner History

Party NameMyriad Genetics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84116
Party NameMyriad Genetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108
Party NameMyriad Genetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events

Event DateEvent Description
Thursday, May 9, 2013NEW APPLICATION ENTERED
Monday, May 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 14, 2013NOTICE OF PSEUDO MARK E-MAILED
Thursday, August 22, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NON-FINAL ACTION WRITTEN
Friday, August 23, 2013NON-FINAL ACTION E-MAILED
Friday, August 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 18, 2014FINAL REFUSAL WRITTEN
Tuesday, March 18, 2014FINAL REFUSAL E-MAILED
Tuesday, March 18, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 18, 2014EXPARTE APPEAL RECEIVED AT TTAB
Thursday, September 18, 2014JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, September 18, 2014EX PARTE APPEAL-INSTITUTED
Thursday, September 18, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, September 18, 2014TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, September 22, 2014ASSIGNED TO LIE
Friday, September 26, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 26, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 1, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 8, 2014ACTION CONTINUING FINAL - COMPLETED
Monday, December 8, 2014ACTION DENYING REQ FOR RECON E-MAILED
Monday, December 8, 2014NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, February 9, 2015JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, March 11, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 11, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 27, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, March 27, 2015EXAMINERS AMENDMENT E-MAILED
Friday, March 27, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 27, 2015EXAMINER'S AMENDMENT ENTERED
Friday, March 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 27, 2015EXPARTE APPEAL TERMINATED
Monday, April 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2015TEAS STATEMENT OF USE RECEIVED
Saturday, October 3, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 29, 2015USE AMENDMENT FILED
Tuesday, October 6, 2015STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 24, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, November 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 22, 2021TEAS SECTION 8 & 15 RECEIVED
Friday, February 11, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 11, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 11, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 26, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, April 26, 2022WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, May 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 26, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, July 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 24, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 2, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, October 16, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

myrisk myriad disease gene risk excluding medical cardiovascular profiles expression mutations molecular